Senti Biosciences Holdings (SNTI) Research & Development (2021 - 2026)
Senti Biosciences Holdings' Research & Development came in at $7.77 million for Q2 2026, down 22.6% from $10.03 million a year earlier.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Research & Development (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Senti Biosciences Holdings reported Research & Development of $36.07 million, up 0.9% year-over-year; for FY2025, it came in at $37.59 million, up 9.4% from FY2024.
- Research & Development has increased in each of the last four years, with a four-year compound annual growth rate of 14.4% (FY2021 to FY2025).
- Going back by year, Research & Development was $34.36 million in FY2024 (+6.9%), $32.15 million in FY2023 (+14.2%), $28.15 million in FY2022 (+28.2%) and $21.96 million in FY2021.
- The five-year range for quarterly Research & Development is $5.41 million (Q3 2021) to $10.52 million (Q3 2025).
- Year-over-year, Research & Development increased in three of the last seven quarters, with an average decline of 0.8%.
- The fastest year-over-year change in Research & Development over five years came in Q2 2022 (growth of 76.6%), and the weakest in Q2 2023 (a decline of 25.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.39 Bn | 1,131.97 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 634.39 Bn | 552.91 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 502.68 Bn | 475.79 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 377.37 Bn | 331.74 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 266.55 Bn | 240.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 240.56 Bn | 195.96 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.19 Bn | 167.38 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Senti Biosciences Holdings | 6.23 Mn | -50.53 Mn | - | 7.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.77 Mn |
| Dec 31, 2025 | 7.76 Mn |
| Sep 30, 2025 | 10.52 Mn |
| Jun 30, 2025 | 10.03 Mn |
| Mar 31, 2025 | 9.28 Mn |
| Dec 31, 2024 | 7.77 Mn |
| Sep 30, 2024 | 8.66 Mn |
| Jun 30, 2024 | 9.15 Mn |
| Mar 31, 2024 | 8.78 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 7.04 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 9.25 Mn |
| Mar 31, 2022 | 7.60 Mn |
| Dec 31, 2021 | 6.41 Mn |
| Sep 30, 2021 | 5.41 Mn |
| Jun 30, 2021 | 5.24 Mn |
API Access
Senti Biosciences Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SNTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SNTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SNTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();